Academic Journal
Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome
| العنوان: | Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome |
|---|---|
| المؤلفون: | Holkova, Beata, Shafer, Danielle, Yazbeck, Victor, Dave, Sandeep, Bose, Prithviraj, Tombes, Mary Beth, Shrader, Ellen, Wan, Wen, Bandyopadhyay, Dipankar, Weir, Caryn, Collins, Elizabeth B., Garnett, Amanda, Kmieciak, Maciej, Roberts, John D., Garcia-Manero, Guillermo, Grant, Steven |
| المصدر: | Leukemia & Lymphoma ; volume 62, issue 5, page 1187-1194 ; ISSN 1042-8194 1029-2403 |
| بيانات النشر: | Informa UK Limited |
| سنة النشر: | 2020 |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1080/10428194.2020.1861270 |
| الاتاحة: | http://dx.doi.org/10.1080/10428194.2020.1861270 https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1861270 |
| رقم الانضمام: | edsbas.192A54F3 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1080/10428194.2020.1861270 |
|---|